SecurityTRTX / TPG RE Finance Trust, Inc. (87266M107)
CEO & PresidentGuggenheim Greta
Institutional Owners68
Institutional Shares24,254,378 - 41.08%
Common Stock Shares Outstanding59,039,965 shares (as of 2018-06-30)
Institutional Value$ 1,569,831,000 USD

Institutional Stock Ownership and Shareholders

TRTX / TPG RE Finance Trust, Inc. Institutional Ownership

TPG RE Finance Trust, Inc. (NYSE:TRTX) has 68 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 24,254,378 shares. Largest shareholders include TPG Group Holdings (SBS) Advisors, Inc., BlackRock Inc., Nan Shan Life Insurance Co., Ltd., Vanguard Group Inc, Nuveen Asset Management, LLC, State Street Corp, Clearbridge Investments, LLC, Timbercreek Asset Management Ltd., Blackstone Group L.P., and Northern Trust Corp.
TPG RE Finance Trust, Inc. (NYSE:TRTX) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-08-14 13F-HR/A CITADEL ADVISORS LLC 45,681 928
2018-07-30 13F-HR SIMPLEX TRADING, LLC 88 0 -100.00 1 0 -100.00
2018-09-05 13F-HR/A TPG Group Holdings (SBS) Advisors, Inc. 6,505,167 6,505,167 0.00 129,388 132,185 2.16
2018-07-27 13F-HR PIEDMONT INVESTMENT ADVISORS LLC 546 11
2018-08-14 13F-HR CREDIT SUISSE AG/ 17,763 21,646 21.86 353 439 24.36
2018-08-10 13F-HR PNC FINANCIAL SERVICES GROUP, INC. 29 29 0.00 1 1 0.00
2018-08-14 13F-HR A.R.T. Advisors, LLC 10,500 0 -100.00 208 0 -100.00
2018-08-14 13F-HR TEACHERS ADVISORS INC 29,782 57,949 94.58 592 1,178 98.99
2018-09-18 13F-HR/A NORTHERN TRUST CORP 205,914 311,353 51.21 4,096 6,327 54.47
2018-08-17 13F-HR/A NOMURA HOLDINGS INC 58,255 0 -100.00 1,160 0 -100.00
2018-08-13 13F-HR FIRST REPUBLIC INVESTMENT MANAGEMENT, INC. 66,842 116,294 73.98 1,330 2,363 77.67
2018-08-14 13F-HR GEODE CAPITAL MANAGEMENT, LLC 141,579 204,544 44.47 2,816 4,156 47.59
2018-08-13 13F-HR ALLIANCEBERNSTEIN L.P. 12,200 15,300 25.41 243 311 27.98
2018-08-14 13F-HR STATE STREET CORP 468,698 612,949 30.78 9,325 12,452 33.53
2018-08-17 13F-HR Matarin Capital Management, LLC 35,633 724,063
2018-08-06 13F-HR STRS OHIO 5,900 9,200 55.93 117 186 58.97
2018-08-03 13F-HR Dean Capital Investments Management, Llc 26,520 539
2018-08-06 13F-HR Zurcher Kantonalbank (Zurich Cantonalbank) 2,119 43
2018-08-14 13F-HR Schonfeld Strategic Advisors LLC 95,403 0 -100.00 1,898 0 -100.00
2018-08-14 13F-HR D. E. Shaw & Co., Inc. 17,772 33,629 89.22 353 683 93.48
2018-08-14 13F-HR BANK OF AMERICA CORP /DE/ 38,055 146,237 284.28 757 2,972 292.60
2018-08-13 13F-HR Altshuler Shaham Ltd 645 1,139 76.59 13 23 76.92
2018-08-07 13F-HR SG Americas Securities, LLC 6,152 125
2018-08-10 13F-HR GREAT WEST LIFE ASSURANCE CO /CAN/ 1,490 1,490 0.00 30 30 0.00
2018-08-14 13F-HR UBS Group AG 3,911 26,367 574.18 78 536 587.18
2018-08-14 13F-HR BALYASNY ASSET MANAGEMENT LLC 20,592 0 -100.00 410 0 -100.00
2018-08-14 13F-HR BARCLAYS PLC 0 2,305 0 47
2018-08-07 13F-HR IFP Advisors, Inc 605 605 0.00 12 12 0.00
2018-08-14 13F-HR DEUTSCHE BANK AG\ 22,142 50,307 127.20 439 1,020 132.35
2018-08-13 13F-HR PARAMETRIC PORTFOLIO ASSOCIATES LLC 10,067 16,612 65.01 200 338 69.00
2018-08-08 13F-HR SCHWAB CHARLES INVESTMENT MANAGEMENT INC 60,704 96,137 58.37 1,208 1,954 61.75
2018-08-14 13F-HR Parallax Volatility Advisers, L.P. 2,904 0 -100.00 58 0 -100.00
2018-08-14 13F-HR TWO SIGMA INVESTMENTS LLC 242,136 162,077 -33.06 4,816 3,293 -31.62
2018-08-10 13F-HR CITIGROUP INC 2,468 6,496 163.21 49 132 169.39
2018-08-14 13F-HR Invesco Ltd. 35,739 23,270 -34.89 711 473 -33.47
2018-08-13 13F-HR Stockman Asset Management 27,250 554
2018-08-14 13F-HR VANGUARD GROUP INC 3,042,643 3,309,134 8.76 60,519 67,241 11.11
2018-08-14 13F-HR TWO SIGMA ADVISERS, LP 117,800 130,600 10.87 2,343 2,654 13.27
2018-07-13 13F-HR BANK OF MONTREAL /CAN/ 223 5
2018-08-08 13F-HR Private Capital Group, Llc 58 58 0.00 1 1 0.00
2018-08-13 13F-HR Nan Shan Life Insurance Co., Ltd. 3,384,135 3,384,135 0.00 67,310 68,766 2.16
2018-08-13 13F-HR APG Asset Management N.V. 48,100 837
2018-08-14 13F-HR QS Investors, LLC 33 19,317 58,436.36 1 393 39,200.00
2018-08-13 13F-HR Hillsdale Investment Management Inc. 490 550 12.24 10 11 10.00
2018-08-14 13F-HR ROYAL BANK OF CANADA 8 2,460 30,650.00 0 50
2018-08-14 13F-HR GOLDMAN SACHS GROUP INC 174,679 62,127 -64.43 3,474 1,262 -63.67
2018-08-09 13F-HR BlackRock Inc. 5,370,428 5,704,439 6.22 106,818 115,915 8.52
2018-08-02 13F-HR Atlantic Trust Group, LLC 68,818 71,109 3.33 1,369 1,445 5.55
2018-07-25 13F-HR BNP PARIBAS ARBITRAGE, SA 4,231 2,230 -47.29 84,155 45,314 -46.15
2018-08-13 13F-HR PRUDENTIAL FINANCIAL INC 14,732 300
2018-08-13 13F-HR Resource America, Inc. 24,985 167,663 571.05 496,952 3,407 -99.31
2018-08-06 13F-HR RHUMBLINE ADVISERS 18,851 31,563 67.43 375 641 70.93
2018-08-14 13F-HR ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 56,165 62,565 11.39 1,117 1,271 13.79
2018-08-08 13F-HR AMERICAN INTERNATIONAL GROUP INC 13,226 20,469 54.76 263 416 58.17
2018-08-14 13F-HR MILLENNIUM MANAGEMENT LLC 28,010 0 -100.00 557 0 -100.00
2018-08-13 13F-HR Advisor Group, Inc. 310 310 0.00 6 6 0.00
2018-08-10 13F-HR Legal & General Group Plc 3,417 5,359 56.83 68 109 60.29
2018-08-14 13F-HR MORGAN STANLEY 48,447 68,473 41.34 964 1,391 44.29
2018-08-14 13F-HR UBS ASSET MANAGEMENT AMERICAS INC 15,200 15,200 0.00 302,328 308,864 2.16
2018-08-14 13F-HR Indaba Capital Management, L.P. 667,555 0 -100.00 13,278 0 -100.00
2018-08-13 13F-HR OXFORD ASSET MANAGEMENT 11,297 0 -100.00 225 0 -100.00
2018-08-14 13F-HR JP Morgan Chase & Co 171,952 301,634 75.42 3,420 6,130 79.24
2018-08-10 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 13,700 36,348 165.31 272 739 171.69
2018-08-15 13F-HR METROPOLITAN LIFE INSURANCE CO/NY 7,037 0 -100.00 139,966 0 -100.00
2018-08-14 13F-HR Nuveen Asset Management, LLC 1,020,865 668,842 -34.48 20,305 13,591 -33.07
2018-08-13 13F-HR Ameritas Investment Partners, Inc. 1,747 2,646 51.46 35 54 54.29
2018-08-14 13F-HR CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 31,512 48,087 52.60 627 977 55.82
2018-08-14 13F-HR Timbercreek Asset Management Ltd. 253,271 410,023 61.89 673 8,332 1,138.04
2018-08-15 13F-HR Metlife Investment Advisors, Llc 10,006 0 -100.00 199 0 -100.00
2018-08-09 13F-HR Swiss National Bank 62,200 46,200 -25.72 1,237 939 -24.09
2018-08-14 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 16,671 23,300 39.76 332 473 42.47
2018-08-14 13F-HR Tower Research Capital LLC (TRC) 0 308 0 6
2018-07-24 13F-HR ACADIAN ASSET MANAGEMENT LLC 4,274 87
2018-05-11 13F-HR CITIGROUP INC 2,549 2,468 -3.18 49 49 0.00
2018-02-12 13F-HR Hutchin Hill Capital, LP 27,700 27,700 0.00 548 528 -3.65
2018-08-14 13F-HR Blackstone Group L.P. 452,800 335,203 -25.97 9,006 6,811 -24.37
2018-08-14 13F-HR Cubist Systematic Strategies, LLC 31,383 0 -100.00 624 0 -100.00
2018-08-14 13F-HR Clearbridge Investments, LLC 580,610 548,750 -5.49 11,548 11,151 -3.44
2018-08-14 13F-HR TIAA CREF INVESTMENT MANAGEMENT LLC 39,614 55,390 39.82 788 1,126 42.89
2018-08-03 13F-HR SEI INVESTMENTS CO 67 106 58.21 1 2 100.00
2018-08-01 13F-HR WELLS FARGO & COMPANY/MN 28,014 57,280 104.47 558 1,163 108.42

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Related News Stories

Diversification Or Diworsification?

2018-08-20 seekingalpha
I’m certainly not Warren Buffett, so I must spread my hard-earned capital across multiple property sectors and sub-sectors. (37-1)

TPG RE Finance Trust (TRTX) CEO Greta Guggenheim on Q2 2018 Results - Earnings Call Transcript

2018-08-07 seekingalpha
TPG RE Finance Trust (NYSE:TRTX) Q2 2018 Earnings Conference Call August 7, 2018 8:30 AM ET

Here's Why You Should Add CBRE Group (CBRE) to Your Portfolio

2018-08-07 zacks
Shares of CBRE Group Inc. (CBRE - Free Report) have gained 6.3% in the past three months compared with its industry’s growth of 5.2%. Further, the trend in current-year earnings estimate revisions indicates a solid outlook for the company. The fundamentals appear solid for this Zacks Rank #2 (Buy) stock and there are enough scope for its price appreciation in the near term. In fact, CBRE Group has a robust scale as the largest commercial real estate services and investment firm (based on 2017 revenues). (5-0)

TPG RE Finance Trust 2018 Q2 - Results - Earnings Call Slides

2018-08-07 seekingalpha
The following slide deck was published by TPG RE Finance Trust in conjunction with their 2018 Q2 earnings call.

TPG RE Finance Trust (TRTX) Meets Q2 Earnings Estimates

2018-08-07 zacks
TPG RE Finance Trust (TRTX - Free Report) just came out with quarterly earnings of $0.44 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.64 per share a year ago. These figures are adjusted for non-recurring items. (1-0)

Stocks To Watch: Prime Time In Retail

2018-07-14 seekingalpha
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. (285-0)

Wendy Silverstein Plans Exit From New York REIT - Bloomberg

2018-07-13 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. (0-1)

REML's 22.2% Yield Makes It The Highest Current Yield Of The Leveraged ETNs, But Risks Persist

2018-07-02 seekingalpha
The July 2018 REML dividend will bring, on a monthly compounded annualized rate, its yield to 22.2%. (139-0)

The Safest Dividend Is The One That's Just Been Raised

2018-06-11 seekingalpha
TRTX has been a great pick and I am so glad that I took the time to include this new REIT in our research. (13-1)

Amateur Night At Apollo

2018-05-18 seekingalpha
As my readers know, in addition to equity REITs I also cover the growing commercial mortgage REIT sector. (35-0)

CUSIP: 87266M107